WallStreetZenWallStreetZen

NASDAQ: IRLA
Irulya Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Irulya Therapeutics revenue was $0.00 for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IRLA annual revenue was $0.0, with N/A growth year-over-year.

IRLA revenue history

Current Revenue
$0.0
Current Earnings
-$92.5M
Current Profit Margin
0%

Be the first to know when IRLA announces revenue.

IRLA Revenue History By Year

IRLA Yearly RevenueIRLA RevenueIRLA ChangeIRLA Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Irulya Therapeutics Revenue FAQ

What was IRLA's revenue last quarter?

On Aug 17, 2026, Irulya Therapeutics (NASDAQ: IRLA) reported Q2 2026 revenue of $0.00 up N/A year over year. In the same quarter last year, Irulya Therapeutics's revenue was $0.00.

What was Irulya Therapeutics's revenue in 2025?

Irulya Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Irulya Therapeutics make in a day?

Based on Irulya Therapeutics annual revenue for the past five years, IRLA makes an average of $0.00 per day.

What was Irulya Therapeutics's annual revenue growth in the past year?

As of Q4 2026, Irulya Therapeutics's revenue has grown null year over year. Irulya Therapeutics's revenue in the past year totaled $0.00.

How much does Irulya Therapeutics make in a year?

Irulya Therapeutics's revenue by year for the past five years is:
  • Irulya Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Irulya Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
  • Irulya Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Irulya Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Irulya Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.